Relativity Unveils Its Fifth Annual AI Visionaries List Ahead of Legalweek 2026
Amplifying the voices guiding the future of AI in the legal profession CHICAGO, March 2, 2026 /PRNewswire/ -- Relativity, a leading legal data intelligence company, today announced its fifth annual list of AI Visionaries. The list honors individuals...
The Sigourney Award-2026 Now Accepting Applications for Psychoanalytic Innovation
International Prize Honors Trailblazing Work Advancing Psychoanalytic Thought and Principles — Cash Award and Global Recognition SAN FRANCISCO, March 2, 2026 /PRNewswire/ -- The Sigourney Award Trust welcomes applications for The Sigourney...
XellSmart Receives Fourth Consecutive US FDA & China NMPA IND Clearance for MSA-P iPSC-derived Cell Therapy
SUZHOU, China, March 2, 2026 /PRNewswire/ -- In February 2026, XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for Phase I/II registrational clinical trial entry with its...
Beko Wins Four iF DESIGN AWARDS 2026, Highlighting Global Leadership in Connected, User-Centered Innovation
129-member panel recognises Beko's refrigerators, digital user experiences and coffee maker interface among world's best ISTANBUL, March 2, 2026 /PRNewswire/ -- Beko, leading global home appliances company, has been honored with four iF DESIGN...
Superior Efficacy and Long-acting: LongBio Announces Positive Topline Results from Phase II CSU Trial of Next-Generation Anti-IgE Therapy, LP-003 in Head-to-Head Comparison with Xolair®
PHILADELPHIA, March 2, 2026 /PRNewswire/ -- LongBio Pharma (Suzhou) Co., Ltd. ("LongBio"), a clinical-stage biotech company focused on discovery and development of biologics targeting allergic and autoimmune diseases, proudly announced positive...
ReviR Therapeutics Announces First Participant Dosed in Phase 1 Study and Secures CDE Clearance for Two Orphan Indications in China, Supporting Future U.S. Expansion Strategy
Milestone marks the first clinical program for Charcot-Marie-Tooth disease and Vanishing White Matter disease. SAN FRANCISCO and SHANGHAI, March 2, 2026 /PRNewswire/ -- ReviR Therapeutics, a clinical-stage biotechnology company pioneering AI-driven...
Dream Pairs Kids Launches Spring 2026 Collection Designed for Kids' Every Spring Adventure
NEW YORK, March 2, 2026 /PRNewswire/ -- As spring calendars begin filling with family trips, playground afternoons, rainy-day puddle jumping, and picture-perfect celebrations, Dream Pairs Kids unveils a collection designed to keep pace with every...
GigaMedia Announces Extension of Aeolus Convertible Note
TAIPEI, March 2, 2026 /PRNewswire/ -- GigaMedia Limited (NASDAQ: GIGM) today announced that the Company has entered into and executed with Aeolus Robotics Corporation ("Aeolus") an agreement of amendment to the Aeolus convertible promissory note...